Joanne Kurtzberg, M.D., Chief

Normal and malignant hematopoiesis.

Staci Arnold, MD 

Cost-benefit analysis of hospital/ patient care interventions;
hematology-oncology health services research;
palliative care and quality of life. 

Timothy A. Driscoll, M.D.

Acid sphingomyelinase and intracellular ceramide.

Paul L. Martin, M.D., Ph.D.

Bone marrow transplant, leukemia, use of fluorescent  in situ hybridization to detect chromosome abnormalities, treatment of neuroblastoma.

Suhag H. Parikh, M.D.

Reduced intensity conditioning in non-malignant disorders (including sickle cell disease, thalassemia, metabolic disorders and immune deficiency disorders).

Vinod Prasad, M.D.

Histocompatibility and other determinants of alloreactivity, hematopoietic stem cell transplants, post transplant viral infection.

Paul Szabolcs, M.D.

Develop strategies to diagnose, predict, and therapeutically accelerate immune recovery. Design less intensive conditioning and graft engineering methods to reduce morbidity and  enhance graft tolerance.